论文部分内容阅读
目的探讨妊娠晚期超敏C反应蛋白(hsCRP)对子痫前期患者妊娠结局的影响。方法妊娠晚期入院行免疫比浊法检测孕妇空腹血hsCRP水平,观察患者妊娠结局。结果妊娠晚期hsCRP水平异常增加子痫前期孕妇发生早早产风险,但是不增加早产、新生儿低体重、引产或死胎风险。hsCRP水平与子痫前期严重程度、新生儿胎龄、新生儿体重无统计学相关性(P>0.05)。结论妊娠晚期hsCRP对子痫前期孕妇妊娠不良结局预测价值不大。
Objective To investigate the effect of hsCRP in pregnancy on pregnancy outcome in patients with preeclampsia. Methods Immune turbidimetry was used to detect the level of hsCRP in pregnant women during the third trimester of pregnancy. The pregnancy outcome was observed. Results Abnormal increase of hsCRP levels in late pregnancy Risk of premature birth in pre-eclampsia, but did not increase the risk of premature birth, low birth weight, induced abortion or stillbirth. There was no significant correlation between the level of hsCRP and the severity of preeclampsia, gestational age of newborns and weight of neonates (P> 0.05). Conclusions hsCRP in late pregnancy has little value in predicting adverse pregnancy outcomes in pregnant women with preeclampsia.